663 related articles for article (PubMed ID: 27161376)
1. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
[TBL] [Abstract][Full Text] [Related]
2. Amino acids inhibit kynurenic acid formation via suppression of kynurenine uptake or kynurenic acid synthesis in rat brain in vitro.
Sekine A; Okamoto M; Kanatani Y; Sano M; Shibata K; Fukuwatari T
Springerplus; 2015; 4():48. PubMed ID: 25674503
[TBL] [Abstract][Full Text] [Related]
3. Acute liver failure increases kynurenic acid production in rat brain via changes in tryptophan metabolism in the periphery.
Sekine A; Fukuwatari T
Neurosci Lett; 2019 May; 701():14-19. PubMed ID: 30738081
[TBL] [Abstract][Full Text] [Related]
4. Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers.
Fukushima T; Sone Y; Mitsuhashi S; Tomiya M; Toyo'oka T
Chirality; 2009 Apr; 21(4):468-72. PubMed ID: 18655158
[TBL] [Abstract][Full Text] [Related]
5. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
[TBL] [Abstract][Full Text] [Related]
6. Possibility of Amino Acid Treatment to Prevent the Psychiatric Disorders via Modulation of the Production of Tryptophan Metabolite Kynurenic Acid.
Fukuwatari T
Nutrients; 2020 May; 12(5):. PubMed ID: 32414200
[TBL] [Abstract][Full Text] [Related]
7. High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum.
Okuno A; Fukuwatari T; Shibata K
J Neurochem; 2011 Sep; 118(5):796-805. PubMed ID: 21711351
[TBL] [Abstract][Full Text] [Related]
8. Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine.
Turski WA; Gramsbergen JB; Traitler H; Schwarcz R
J Neurochem; 1989 May; 52(5):1629-36. PubMed ID: 2709016
[TBL] [Abstract][Full Text] [Related]
9. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.
Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX
J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133
[TBL] [Abstract][Full Text] [Related]
10. Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.
Akagbosu CO; Evans GC; Gulick D; Suckow RF; Bucci DJ
Schizophr Bull; 2012 Jun; 38(4):769-78. PubMed ID: 21172906
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
[TBL] [Abstract][Full Text] [Related]
12. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine metabolism in Alzheimer's disease.
Baran H; Jellinger K; Deecke L
J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937
[TBL] [Abstract][Full Text] [Related]
14. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.
Hilmas C; Pereira EF; Alkondon M; Rassoulpour A; Schwarcz R; Albuquerque EX
J Neurosci; 2001 Oct; 21(19):7463-73. PubMed ID: 11567036
[TBL] [Abstract][Full Text] [Related]
15. Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task.
Phenis D; Vunck SA; Valentini V; Arias H; Schwarcz R; Bruno JP
Psychopharmacology (Berl); 2020 Jun; 237(6):1723-1735. PubMed ID: 32162104
[TBL] [Abstract][Full Text] [Related]
16. Alternative kynurenic acid synthesis routes studied in the rat cerebellum.
Blanco Ayala T; Lugo Huitrón R; Carmona Aparicio L; Ramírez Ortega D; González Esquivel D; Pedraza Chaverrí J; Pérez de la Cruz G; Ríos C; Schwarcz R; Pérez de la Cruz V
Front Cell Neurosci; 2015; 9():178. PubMed ID: 26041992
[TBL] [Abstract][Full Text] [Related]
17. Kynurenate production by cultured human astrocytes.
Kiss C; Ceresoli-Borroni G; Guidetti P; Zielke CL; Zielke HR; Schwarcz R
J Neural Transm (Vienna); 2003 Jan; 110(1):1-14. PubMed ID: 12541009
[TBL] [Abstract][Full Text] [Related]
18. The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease.
Beaumont V; Mrzljak L; Dijkman U; Freije R; Heins M; Rassoulpour A; Tombaugh G; Gelman S; Bradaia A; Steidl E; Gleyzes M; Heikkinen T; Lehtimäki K; Puoliväli J; Kontkanen O; Javier RM; Neagoe I; Deisemann H; Winkler D; Ebneth A; Khetarpal V; Toledo-Sherman L; Dominguez C; Park LC; Munoz-Sanjuan I
Exp Neurol; 2016 Aug; 282():99-118. PubMed ID: 27163548
[TBL] [Abstract][Full Text] [Related]
19. L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning.
Chess AC; Landers AM; Bucci DJ
Behav Brain Res; 2009 Aug; 201(2):325-31. PubMed ID: 19428652
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]